menu ☰
menu ˟

Ipilimumab shows promise for patients who relapse following HSCT

13 Jul 2016
Ipilimumab induced complete responses among patients with hematologic malignancies who relapsed following allogeneic hematopoietic stem cell transplantation, according to the results of a study published in The New England Journal of Medicine.Further...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.